Dr. Reddy's Eyes 2012 Launch Of Generic Clarinex
Schering Corp., Sepracor Inc. and Dr. Reddy's Laboratories Ltd. have struck settlement deals that should resolve litigation and allow the India-based generics maker to enter the $362 million annual U.S. market...To view the full article, register now.
Already a subscriber? Click here to view full article